GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mayne Pharma Group Ltd (OTCPK:MAYNF) » Definitions » Asset Turnover

MAYNF (Mayne Pharma Group) Asset Turnover : 0.18 (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Mayne Pharma Group Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Mayne Pharma Group's Revenue for the six months ended in Dec. 2024 was $134.4 Mil. Mayne Pharma Group's Total Assets for the quarter that ended in Dec. 2024 was $737.6 Mil. Therefore, Mayne Pharma Group's Asset Turnover for the quarter that ended in Dec. 2024 was 0.18.

Asset Turnover is linked to ROE % through Du Pont Formula. Mayne Pharma Group's annualized ROE % for the quarter that ended in Dec. 2024 was -11.08%. It is also linked to ROA % through Du Pont Formula. Mayne Pharma Group's annualized ROA % for the quarter that ended in Dec. 2024 was -4.39%.


Mayne Pharma Group Asset Turnover Historical Data

The historical data trend for Mayne Pharma Group's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mayne Pharma Group Asset Turnover Chart

Mayne Pharma Group Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.26 0.29 0.14 0.32

Mayne Pharma Group Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.06 0.16 0.17 0.18

Competitive Comparison of Mayne Pharma Group's Asset Turnover

For the Drug Manufacturers - General subindustry, Mayne Pharma Group's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mayne Pharma Group's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mayne Pharma Group's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Mayne Pharma Group's Asset Turnover falls into.


;
;

Mayne Pharma Group Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Mayne Pharma Group's Asset Turnover for the fiscal year that ended in Jun. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Jun. 2024 )/( (Total Assets (A: Jun. 2023 )+Total Assets (A: Jun. 2024 ))/ count )
=257.572/( (837.15+759.082)/ 2 )
=257.572/798.116
=0.32

Mayne Pharma Group's Asset Turnover for the quarter that ended in Dec. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=134.4/( (759.082+716.108)/ 2 )
=134.4/737.595
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Mayne Pharma Group  (OTCPK:MAYNF) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Mayne Pharma Group's annulized ROE % for the quarter that ended in Dec. 2024 is

ROE %**(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=-32.356/292.086
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-32.356 / 268.8)*(268.8 / 737.595)*(737.595/ 292.086)
=Net Margin %*Asset Turnover*Equity Multiplier
=-12.04 %*0.3644*2.5253
=ROA %*Equity Multiplier
=-4.39 %*2.5253
=-11.08 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2024) net income data. The Revenue data used here is two times the semi-annual (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Mayne Pharma Group's annulized ROA % for the quarter that ended in Dec. 2024 is

ROA %(Q: Dec. 2024 )
=Net Income/Total Assets
=-32.356/737.595
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-32.356 / 268.8)*(268.8 / 737.595)
=Net Margin %*Asset Turnover
=-12.04 %*0.3644
=-4.39 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2024) net income data. The Revenue data used here is two times the semi-annual (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Mayne Pharma Group Asset Turnover Related Terms

Thank you for viewing the detailed overview of Mayne Pharma Group's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Mayne Pharma Group Business Description

Traded in Other Exchanges
Address
1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106
Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women's Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women's Health segment distributes branded women's health products in the U.S. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.